A CONSUMER'S GUIDE TO MONITORING PSYCHOTROPIC MEDICATION FOR INDIVIDUALS WITH AUTISM SPECTRUM DISORDERS
Saved in:
SCHALL, C., A CONSUMER'S GUIDE TO MONITORING PSYCHOTROPIC MEDICATION FOR INDIVIDUALS WITH AUTISM SPECTRUM DISORDERS. FOCUS ON AUTISM AND OTHER DEVELOPMENTAL DISABILITIES, Vol. 17, no. 4 (2002), p. 229-235.
Ref.
127848
Sted:
SIIS SIIS Madrid R.1543
Palabras clave:
Autismo, Discapacidad, Fármacos, Psicótropos, Trastornos del espectro autista, Tratamiento médico
Autismo, Discapacidad, Fármacos, Psicótropos, Trastornos del espectro autista, Tratamiento médico
Lignende værker: A CONSUMER'S GUIDE TO MONITORING PSYCHOTROPIC MEDICATION FOR INDIVIDUALS WITH AUTISM SPECTRUM DISORDERS
- PSYCHOTROPIC MEDICATION USE AMONG CHILDREN WITH AUTISM SPECTRUM DISORDERS ENROLLED IN A NATIONAL REGISTRY, 2007-2008
- GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
- A CASE STUDY OF A YOUNG MAN WITH INTELLECTUAL DISABILITY, MITOCHONDRIAL DISORDER, EPILEPSY, AUTISM AND PSYCHOSIS: HOW DID WE DECIDE WHICH PSYCHOTROPIC DRUG TO USE?
- AN EXAMINATION OF PSYCHOTROPIC MEDICATION SIDE EFFECTS: DOES TAKING A GREATER NUMBER OF PSYCHOTROPIC MEDICATIONS FROM DIFFERENT CLASSES AFFECT PRESENTATION OF SIDE EFFECTS IN ADULTS WITH ID?
- CHILDREN WITH AUTISM SPECTRUM DISORDER: MEDICINE TODAY AND IN THE NEW MILLENNIUM
- DESIGNING AN OUTCOME STUDY TO MONITOR THE PROGRESS OF STUDENTS WITH AUTISM SPECTRUM DISORDERS